Company: INMB
Filing Date: 2025-06-16
Form Type: S-8
Source: 0001213900-25-054427
Chunk: 12

Company: Inmune Bio, Inc.
Filing Date: 2025-06-16
Form: S-8
Chunk 12
---
, at prices then related to the then-current market price or in negotiated transactions.
In connection with resales of the shares of common stock, broker-dealers may pay to or receive from the purchasers of shares commissions
as described above.

If the selling stockholders enter into arrangements
with brokers or dealers, as described above, we are obligated to file a post-effective amendment to this registration statement disclosing
such arrangements, including the names of any broker-dealers acting as underwriters.

The selling stockholders and any broker-dealers
or agents that participate with the selling stockholders in the sale of the shares of common stock may be deemed to be “underwriters”
within the meaning of the Securities Act. In that event, any commissions received by broker-dealers or agents and any profit on the resale
of the shares of common stock purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act.

Sales Pursuant to Rule 144

Any shares of common stock covered by this reoffer
prospectus which qualify for sale pursuant to Rule 144 under the Securities Act may be sold under Rule 144 rather than pursuant to this
reoffer prospectus.

Regulation M

The selling stockholders must comply with the
requirements of the Securities Act and the Securities Exchange Act of 1934, as amended (the “Exchange Act”) in the offer and
sale of the common stock. In particular we will advise the selling stockholders that the anti-manipulation rules of Regulation M
under the Exchange Act may apply to sales of shares of common stock in the market and to the activities of the selling stockholders and
their affiliates. Regulation M under the Exchange Act prohibits, with certain exceptions, participants in a distribution from bidding
for, or purchasing for an account in which the participant has a beneficial interest, any of the securities that are the subject of the
distribution.

Accordingly, during such times as a selling stockholder
may be deemed to be engaged in a distribution of the common stock, and therefore be considered to be an underwriter, the selling stockholder
must comply with applicable law and, among other things:

| 1. | may not engage in any stabilization activities in connection with our common stock; |

| 2. | may not cover short sales by purchasing shares while the distribution is taking place; and |

| 3. | may not bid for or purchase any of our securities or attempt to induce any person to purchase any of our securities other than as permitted under the Exchange Act